$COR
Cencora, Inc.
XNYS•Health Care•Wholesale-Drugs, Proprietaries & Druggists' Sundries
$323.85
▲+0.78%+$2.50
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCencora, Inc.
XNYS•Health Care•Wholesale-Drugs, Proprietaries & Druggists' Sundries
Why is COR up today? It is at $323.85 (+0.78%), and our scanner flagged it 58 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment COR spikes, and full due diligence on COR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $COR 58 times in the last 30 days. Create a free account to track $COR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on COR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for COR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystSeptember 25, 2026 - Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Robert E. Sanchez as a newReported #10 on the Fortune 500 and #16 on the Global Fortune 500 with more than $300 billion in annual revenue. Learn more at investor.cencora.com, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 6, 2026 · 5 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Krikorian Lazarus Officer | Sold (automatic/other) | -986 | sold 6.1% | 15K | $299K at $303.18 | Oct 1, 26 |
Sanchez Robert E Director | Acquired (grant/award) | +275 | n/a | 275 | n/a | Oct 1, 26 |
Greenberg Lon R Director | Sold (automatic/other) | -1K | sold 7.0% | 17K | $411K at $321.30 | Sep 16, 26 |
Krikorian Lazarus Officer | Sold (automatic/other) | -985 | sold 5.7% | 16K | $321K at $325.97 | Sep 1, 26 |
Campbell Elizabeth S Officer | Sold (automatic/other) | -11K | sold 37% | 19K | $3.7M at $324.12 | Aug 24, 26 |
Tyler Lauren M Director | Acquired (grant/award) | +97 | added 2.2% | 4K | $30K at $311.34 | Jul 31, 26 |
Cooper Ellen Director | Acquired (grant/award) | +97 | added 12% | 893 | $30K at $311.34 | Jul 31, 26 |
Nally Dennis M Director | Acquired (grant/award) | +113 | added 0.9% | 13K | $35K at $311.34 | Jul 31, 26 |
Campbell Elizabeth S Officer | Acquired (grant/award) | +50 | added 0.2% | 31K | $12K at $240.53 | Jun 30, 26 |
Battaglia Silvana Officer | Acquired (grant/award) | +58 | added 0.2% | 24K | $14K at $240.53 | Jun 30, 26 |
Tyler Lauren M Director | Bought (open market) | +550 | added 14% | 4K | $149K at $270.23 | Jun 22, 26 |
Durcan Dermot Mark Director | Bought (open market) | +4K | added 14% | 32K | $1.1M at $274.19 | Jun 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in wholesale-drugs, proprietaries & druggists' sundries, closest in size first.
Here is the latest on COR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for COR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
COR last traded at $323.85, up 0.78% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Cencora, Inc. (COR) is next expected to report earnings on Wednesday, November 4, 2026 (before open), about 24 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. COR currently has a dividend yield of about 0.74% ($2.40 per share per year). Dividend figures can change; this is not investment advice.
The COR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged COR 58 times in the last 30 days.
COR (Cencora, Inc.) trades on XNYS, with a market cap of about $61.80B in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge COR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$COR discussion
Sign in to ask a question or join the discussion.